The rapid, massive growth of COVID-19 authors in the scientific literature,bioRxiv - Scientific Communication and Education

当前位置： X-MOL 学术 › bioRxiv. Sci. Commun. Educ. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The rapid, massive growth of COVID-19 authors in the scientific literature
bioRxiv - Scientific Communication and Education Pub Date : 2021-08-21 , DOI: 10.1101/2020.12.15.422900
John Ioannidis , Maia Salholz-Hillel , Kevin Boyack , Jeroen Baas

We examined the extent to which the scientific workforce in different fields was engaged in publishing COVID-19-related papers. According to Scopus (data cut, August 1, 2021), 210,183 COVID-19-related publications included 720,801 unique authors, of which 360,005 authors had published at least 5 full papers in their career and 23,520 authors were at the top 2% of their scientific subfield based on a career-long composite citation indicator. The growth of COVID-19 authors was far more rapid and massive compared with cohorts of authors historically publishing on H1N1, Zika, Ebola, HIV/AIDS and tuberculosis. All 174 scientific subfields had some specialists who had published on COVID-19. In 109 of the 174 subfields of science, at least one in ten active, influential (top-2% composite citation indicator) authors in the subfield had authored something on COVID-19. 52 hyper-prolific authors had already at least 60 (and up to 227) COVID-19 publications each. Among the 300 authors with the highest composite citation indicator for their COVID-19 publications, most common countries were USA (n=67), China (n=52), UK (n=32), and Italy (n=18). The rapid and massive involvement of the scientific workforce in COVID-19-related work is unprecedented and creates opportunities and challenges. There is evidence for hyper-prolific productivity.

更新日期：2021-08-24

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文